跳至主要内容
临床试验/CTRI/2024/08/072893
CTRI/2024/08/072893尚未招募3 期

A randomized controlled clinical trial to evaluate the effect of Trayodashanga Guggulu in the management of Osteopenia (Asthimajja kshaya)

Dr.Udit saxena1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年8月26日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Improvement in T score and Reduction of signs and symptoms

研究概览

简要总结

Osteopenia is a clinical term used to describe a decrease in bone mineral density, yet not low enough to meet the diagnostic criteria to be considered Osteoporotic1. Osteopenia, as defined by the World Health Organization (WHO), is a t-score between -1 to -2.5, while values less than -2.5 are diagnostic for Osteopenia.

Decreasing BMD values are reflective of an underlying disruption in the micro architecture of bone and Osteopenia, and Osteoporosis is considered quantitative, not qualitative, disorders of bone mineralization.

The natural bone loss that occurs gradually during adulthood is considered to be the cause of primary form of Osteopenia and secondary form of Osteoporosis. Secondary causes serve to accelerate this process and include lifestyle factors such as alcohol use disorder, smoking, sedentary lifestyle, thin body habitus (BMI under 18.5 kg/m2)

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
40.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.T Score with -1 to -2.5
  • Clinical features of Osteopenia like Extreme fatigue, Body pain, Pain in back, vertebra , hip,distal forearm , tibia or any history of fracture or Minimal trauma.

排除标准

  • patients below the age 40 years and above 70 years, and pre diagnosed with Pathological osteopenia and Osteosarcoma , Hypercalcemia.

结局指标

主要结局

Improvement in T score and Reduction of signs and symptoms

时间窗: 91th days

次要结局

未报告次要终点

研究者

发起方
Dr.Udit saxena
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Udit Saxena

Sri Jayendra Saraswathi Ayurveda College and Hospital, Nazarathpet, Chennai.

研究点 (1)

Loading locations...

相似试验